Rockefeller University
Clinical trials sponsored by Rockefeller University, explained in plain language.
-
New antibody shot aims to tame chronic hepatitis b
Disease control Recruiting nowThis early-stage study tests a single dose of a lab-made antibody (HepB mAb19) in 37 adults with chronic hepatitis B who are already on standard antiviral pills. The main goal is to check safety and how the body processes the antibody, not to cure the infection. Participants will…
Phase: PHASE1 • Sponsor: Rockefeller University • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Scientists investigate why aspirin fails to prevent dangerous pregnancy complication
Knowledge-focused Recruiting nowThis study aims to understand why low-dose aspirin does not always prevent preeclampsia, a serious pregnancy condition that causes high blood pressure. Researchers will look at genetic, laboratory, and clinical factors in 130 women who had preeclampsia before and took aspirin in …
Phase: EARLY_PHASE1 • Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated May 13, 2026 16:04 UTC
-
Scientists seek clues to rare bleeding disorders in blood cell study
Knowledge-focused Recruiting nowThis study aims to learn more about how blood cells work together and what goes wrong in inherited bleeding disorders like Glanzmann thrombasthenia. Researchers will study blood samples from up to 60 healthy volunteers and patients with certain blood or clotting disorders. The go…
Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated May 11, 2026 20:48 UTC